PAVmed Inc.
PAVM
$7.75
$0.111.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.00K | 6.00K | 8.00K | 10.00K | 996.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.00K | 6.00K | 8.00K | 10.00K | 996.00K |
| Cost of Revenue | 55.00K | 41.00K | 36.00K | 48.00K | 1.38M |
| Gross Profit | -50.00K | -35.00K | -28.00K | -38.00K | -385.00K |
| SG&A Expenses | 3.71M | 3.89M | 4.63M | 4.34M | 9.57M |
| Depreciation & Amortization | -- | -- | -- | 0.00 | 82.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.85M | 4.72M | 5.45M | 5.20M | 12.57M |
| Operating Income | -4.84M | -4.72M | -5.45M | -5.19M | -11.58M |
| Income Before Tax | -6.01M | -12.32M | 18.62M | 1.14M | 60.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.01M | -12.32M | 18.62M | 1.14M | 60.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 628.00K | 403.00K | 345.00K | 289.00K | 3.69M |
| Net Income | -5.38M | -11.92M | 18.97M | 1.43M | 64.40M |
| EBIT | -4.84M | -4.72M | -5.45M | -5.19M | -11.58M |
| EBITDA | -4.82M | -4.69M | -5.40M | -5.12M | -11.34M |
| EPS Basic | -8.81 | -22.08 | 38.26 | 3.73 | 192.84 |
| Normalized Basic EPS | -0.46 | -0.87 | -2.33 | -1.75 | -9.22 |
| EPS Diluted | -8.81 | -22.20 | 10.20 | -0.36 | 43.28 |
| Normalized Diluted EPS | -0.46 | -0.87 | -0.62 | -0.14 | -2.07 |
| Average Basic Shares Outstanding | 718.50K | 602.80K | 462.50K | 360.90K | 333.50K |
| Average Diluted Shares Outstanding | 718.50K | 602.80K | 1.75M | 4.40M | 1.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |